This article was originally published here. Sir Jeremy Farrar helped Fauci cover up the origin of COVID, was central in the Recovery and Solidarity trials that overdosed 2600 patients with hydroxychloroquine, now heads to WHO for world takeover. So it is good to read between the lines and see what his forked tongue has to… Read More »
It’s estimated that 1 in 3 Americans is deficient in at least 10 minerals, zinc included.1 Not only does this put them at risk of chronic diseases such as heart disease and diabetes,2 but it may increase risk of death or a hospital stay from COVID-19 if you’re infected.3 Zinc has been acknowledged as an… Read More »
In a series of Twitter posts, The Ethical Skeptic — self-described as a former intelligence officer and strategist — has laid out a series of charts illustrating how cancer deaths are being mislabeled as COVID deaths. The suspicion is that this is an effort to hide the fact that the COVID shots have resulted in… Read More »
July 25, 2022, Chinese officials granted conditional approval to an HIV drug to be used as a COVID treatment. As reported by Reuters:1 “The Azvudine tablet, which China approved in July last year to treat certain HIV-1 virus infections, has been given a conditional green light to treat adult patients with ‘normal type’ COVID, the… Read More »
Pfizer’s Paxlovid was granted emergency use authorization to treat mild to moderate COVID-19 in December 2021.1 The drug consists of nirmatrelvir tablets — the antiviral component — and ritonavir tablets, which are intended to slow the breakdown of nirmatrelvir.2 What started out as a slow rollout — only 40,000 or fewer prescriptions were written for… Read More »
Dr. Ryan Cole, an anatomic clinical pathologist with a subspecialty in skin pathology and postgraduate Ph.D. training in immunology, has been on the frontlines exposing the fraudulent COVID narrative. Since 2004, he’s been operating his own business, a pathology laboratory, which gives him rare freedom and flexibility to comment on what he’s seeing. Most others… Read More »
May 23, 2022, Pfizer-BioNTech1 announced preliminary results from their Phase 2/3 trial evaluating a three-dose vaccine schedule for children 6 months to under 5 years of age would be submitted to the FDA for emergency use authorization (EUA). Many in mainstream media are hailing this development as important to children’s health, writing, “many parents of… Read More »